Cargando…
Tolerability and Efficacy of s.c. IgG Self-Treatment in ME/CFS Patients with IgG/IgG Subclass Deficiency: A Proof-of-Concept Study
Background: Chronic fatigue syndrome (ME/CFS) is a complex disease frequently triggered by infections. IgG substitution may have therapeutic effect both by ameliorating susceptibility to infections and due to immunomodulatory effects. Methods: We conducted a proof of concept open trial with s.c. IgG...
Autores principales: | Scheibenbogen, Carmen, Sotzny, Franziska, Hartwig, Jelka, Bauer, Sandra, Freitag, Helma, Wittke, Kirsten, Doehner, Wolfram, Scherbakov, Nadja, Loebel, Madlen, Grabowski, Patricia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8198960/ https://www.ncbi.nlm.nih.gov/pubmed/34072494 http://dx.doi.org/10.3390/jcm10112420 |
Ejemplares similares
-
IgG stimulated β2 adrenergic receptor activation is attenuated in patients with ME/CFS
por: Hartwig, Jelka, et al.
Publicado: (2020) -
Subclasses of allergen-specific IgG: Serum IgG2 and IgG3 levels are not predicted by IgG1/IgG4 levels
por: MacGlashan, Donald, et al.
Publicado: (2021) -
Factors associated with IgG levels in adults with IgG subclass deficiency
por: Barton, James C., et al.
Publicado: (2021) -
PPD-specific IgG and IgG subclasses in the sera of pulmonary tuberculosis patients.
por: Hwang, P. H., et al.
Publicado: (1993) -
Characterization of adult patients with IgG subclass deficiency and subnormal IgG2
por: Barton, James C., et al.
Publicado: (2020)